Afficher la couverture 'Imprinted antibody responses against SARS-CoV-2 Omicron sublineages | Park, Young-Jun' en grand format
/5

0 avis

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

Archive ouverte

Park, Young-Jun | Pinto, Dora | Walls, Alexandra, C. | Liu, Zhuoming | de Marco, Anna | Benigni, Fabio | Zatta, Fabrizia | Silacci-Fregni, Chiara | Bassi, Jessica | Sprouse, Kaitlin, R. | Addetia, Amin | Bowen, John, E. | Stewart, Cameron | Giurdanella, Martina | Saliba, Christian | Guarino, Barbara | Schmid, Michael, A. | Franko, Nicholas, M. | Logue, Jennifer, K. | Dang, Ha, V. | Hauser, Kevin | Di Iulio, Julia | Rivera, William | Schnell, Gretja | Rajesh, Anushka | Zhou, Jiayi | Farhat, Nisar | Kaiser, Hannah | Montiel-Ruiz, Martin | Noack, Julia | Lempp, Florian, A. | Janer, Javier | Abdelnabi, Rana | Maes, Piet | Ferrari, Paolo | Ceschi, Alessandro | Giannini, Olivier | de Melo, Guilherme Dias | Kergoat, Lauriane | Bourhy, Hervé | Neyts, Johan | Soriaga, Leah | Purcell, Lisa, A. | Snell, Gyorgy | Whelan, Sean P.J. | Lanzavecchia, Antonio | Virgin, Herbert, W. | Piccoli, Luca | Chu, Helen, Y. | Pizzuto, Matteo Samuele | Corti, Davide | Veesler, David

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages carry distinct spike mutations and represent an antigenic shift resulting in escape from antibodies induced by previous infection or vaccination. We show that hybrid immunity or vaccine boosters elicit plasma neutralizing activity against Omicron BA.1, BA.2, BA.2.12.1 and BA.4/5 and that breakthrough infections, but not vaccination-only, induce neutralizing activity in the nasal mucosa. Consistent with immunological imprinting, most antibodies derived from memory B cells or plasma cells of Omicron breakthrough cases cross-react with the Wuhan-Hu-1, BA.1, BA.2, and BA.4/5 receptor-binding domains whereas Omicron primary infections elicit B cells of narrow specificity up to 6 months post infection. Although most clinical antibodies have reduced neutralization of Omicron, we identified an ultrapotent pan-variant neutralizing antibody, that is a strong candidate for clinical development.

Suggestions

Du même auteur

Neutralization, effector function and immune imprinting of Omicron variants

Archive ouverte | Addetia, Amin | CCSD

International audience. Currently circulating SARS-CoV-2 variants have acquired convergent mutations at hot spots in the receptor-binding domain 1 (RBD) of the spike protein. The effects of these mutations on viral ...

A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification

Archive ouverte | Rosen, Laura | CCSD

International audience. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution has resulted in viral escape from clinically authorized monoclonal antibodies (mAbs), creating a need for mAbs that are ...

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Archive ouverte | Piccoli, Luca | CCSD

International audience. Analysis of the specificity and kinetics of neutralizing antibodies (nAbs) elicited by SARS-CoV-2 infection is crucial for understanding immune protection and identifying targets for vaccine ...

Chargement des enrichissements...